CASTLE BIOSCIENCES INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Castle Biosciences Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2018 to Q2 2024.
  • Castle Biosciences Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 28.7M shares, a 7.5% increase year-over-year.
  • Castle Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 26.8M shares, a 2.87% increase from 2022.
  • Castle Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 26.1M shares, a 3.65% increase from 2021.
  • Castle Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 25.1M shares, a 32.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 28.7M +2.01M +7.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 27.5M +878K +3.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 26.8M +748K +2.87% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 26.8M +518K +1.97% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 26.7M +669K +2.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 26.6M +1.18M +4.65% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 26.1M +917K +3.65% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 26.3M +1.03M +4.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 26.1M +973K +3.88% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 25.4M +512K +2.06% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 25.1M +6.21M +32.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 25.3M +5.35M +26.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 25.1M +7.55M +43% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 24.9M +6.18M +33% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 18.9M +10.3M +119% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 19.9M +5.63M +39.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 17.5M +15.4M +715% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 18.7M +16.8M +877% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 8.66M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 14.3M +12.4M +648% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 2.15M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 1.92M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 1.91M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.